5FANG W B, ANDRENYAK D M, MOODY D E, et al. Determination of nalmefene by high-performance liquid chromatography- electrospray ionization-tandem mass spectrometry [ J ]. J Anal Toxicol,2005,29 ( 3 ) : 169-174.
6XIE S, SUCKOW R F, MASON B J,et al. Rapid and sensitive determination of nalmefene in human plasma by gas chromatography-mass spectrometry [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci ,2002.773 ( 2 ) : 143-149.
7DIXON R, HOWES J, GENTILE J, et al. Nalmefene: intravenous safety and kinetics of a new opioid antagonist [ J ]. Clin Pharmacol Ther, 1986, 39(1) : 49-53.
8DIXON R, HOWES J, GENTILE J, et al. Nalmefene: safety and kinetics after single and multiple of a new opioid antagonist [ J]. J Clin Pharmacol, 1987, 27(3): 233-239.
9FRYE R F, MATZKE G R, JALLAD N R, et al. The effect of age on the pharmacokinetics of the opioid antagonist nalmefene [J]. Br J Glin Pharmacol, 1996, 42(3) : 301-306.
10LI P, CHEN X Y, DAI X J, et al. Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study [ J ]. J Chromatography B, 2007, 852 (1-2) : 479-484.
